Syndax Pharmaceuticals' Corporate Minority Round

Syndax Pharmaceuticals raised a round of funding on April 06, 2015. Investors include Merck & Co..

Syndax is a clinical stage biopharmaceutical company developing entinostat as a combination therapy in multiple cancer indications with an initial focus on tumors that have shown sensitivity to immuno…

Articles about Syndax Pharmaceuticals' Corporate Minority Round: